NCT04863001

Brief Summary

This study aims to describe the use of Cardiovascular Drugs in Pediatrics Cardiology unit Assiut University. As regard :

  • indications of use .
  • proper dosage.
  • proper management of side effects of their use.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2021

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

April 28, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

October 1, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2022

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

May 6, 2021

Status Verified

April 1, 2021

Enrollment Period

6 months

First QC Date

April 14, 2021

Last Update Submit

May 3, 2021

Conditions

Antiarrhythmic Toxicity

Outcome Measures

Primary Outcomes (1)

  • descripe the use of antiarrhythmic drugs in pediatrics

    to asses the use of antiarrhythmic drugs in cardiology unit whether its used for proper indications matching with last guidelines or not to asses also dosage (gram per Kg of weight) of each drug used .and detrimine the side effects appear and its proper management. * proper dosage. * proper management of side effects of their use

    one year

Interventions

Antiarrhythmic drugDRUG

all classes of antiarrhythmic drugs used in pediatrics cardiology unit assiut university

Eligibility Criteria

Age1 Month - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

1- Patients' selection:- patients from 1 month age till 18 years on antiarrhythmic medications in Cardiology Unit Assiut University Hospital antiarrhytmic medications .

You may qualify if:

  • All Patients with Arrhythmic cardiac diseases admitted at cardiology unit Assiut University Hospital aged from 1 month to 18 years

You may not qualify if:

  • ● Patients with diseases rather than arrhythmic cardiac diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Podrid PJ. Antiarrhythmic drug selection. Annu Rev Med. 1987;38:1-17. doi: 10.1146/annurev.me.38.020187.000245.

    PMID: 3555284BACKGROUND

MeSH Terms

Interventions

Anti-Arrhythmia Agents

Intervention Hierarchy (Ancestors)

Cardiovascular AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and Uses

Central Study Contacts

Areej makhlouf

CONTACT

01001153846areejmakhlouf2@gmail.com

Salah Eldin Ahmad

CONTACT

S_amry@yahoo.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principle investegator , Areej Tarek Mostafa

Study Record Dates

First Submitted

April 14, 2021

First Posted

April 28, 2021

Study Start

October 1, 2021

Primary Completion

April 1, 2022

Study Completion

October 1, 2022

Last Updated

May 6, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share